A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)
NCT02049281
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
Vintafolide
Sponsor
Endocyte